1
|
Most A, Nordbeck S, Farina N. Iatrogenic hyperchloremia: An overview in hospitalized patients for pharmacists. Am J Health Syst Pharm 2024:zxae086. [PMID: 38530649 DOI: 10.1093/ajhp/zxae086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2024] [Indexed: 03/28/2024] Open
Abstract
DISCLAIMER In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE The purpose of this therapeutic update is to provide pharmacists with a general overview of the pathophysiology of hyperchloremia and describe strategies to help prevent development of this electrolyte abnormality in hospitalized patients. SUMMARY Hyperchloremia is an electrolyte abnormality associated with an increased incidence of acute kidney injury and metabolic acidosis. Intravenous (IV) fluids utilized for volume resuscitation, medication diluents, and total parental nutrition all may contribute to the development of hyperchloremia. Current evidence suggests that administration of balanced crystalloids for either fluid resuscitation or maintenance fluids may impact serum chloride levels and patient outcomes. In multiple randomized controlled trials, administering balanced crystalloids for fluid resuscitation in critically ill patient populations did not decrease mortality. However, further analyses of subpopulations within these trials have demonstrated that patients with sepsis may benefit from receiving balanced crystalloids for initial fluid resuscitation. Results from several small studies suggest that altering the composition of these IV fluids may help prevent development of hyperchloremia. CONCLUSION Management of hyperchloremia is preventative in nature and can be mitigated through management of resuscitation fluids, medication diluents, and total parenteral nutrition. Inpatient pharmacists should be aware of the potential risk of fluid-associated hyperchloremia and assist with optimal fluid management to prevent and manage hyperchloremia.
Collapse
Affiliation(s)
- Amoreena Most
- Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, USA
| | - Sarah Nordbeck
- Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, USA
| | - Nicholas Farina
- Department of Pharmacy, Michigan Medicine, Ann Arbor, MI, USA
| |
Collapse
|
3
|
Airapetian A, Akopov N, Amarian M, Aschenauer EC, Avakian H, Avakian R, Avetissian A, Avetissian E, Bains B, Baumgarten C, Beckmann M, Belostotski S, Belz JE, Benisch T, Bernreuther S, Bianchi N, Blouw J, Böttcher H, Borissov A, Bouwhuis M, Brack J, Brauksiepe S, Braun B, Bray B, Brons S, Brückner W, Brüll A, Bruins EEW, Bulten HJ, Capitani GP, Carter P, Chumney P, Cisbani E, Court GR, Dalpiaz PF, De Sanctis E, De Schepper D, Devitsin E, de Witt Huberts PKA, Di Nezza P, Düren M, Dvoredsky A, Elbakian G, Ely J, Fantoni A, Fechtchenko A, Ferstl M, Fiedler K, Filippone BW, Fischer H, Fox B, Franz J, Frullani S, Funk MA, Gärber Y, Gao H, Garibaldi F, Gavrilov G, Geiger P, Gharibyan V, Golendukhin A, Graw G, Grebeniouk O, Green PW, Greeniaus LG, Grosshauser C, Guidal M, Gute A, Gyurjyan V, Haas JP, Haeberli W, Hansen JO, Hartig M, Hasch D, Häusser O, Heinsius FH, Henderson R, Henoch M, Hertenberger R, Holler Y, Holt RJ, Hoprich W, Ihssen H, Iodice M, Izotov A, Jackson HE, Jgoun A, Kaiser R, Kinney E, Kisselev A, Kitching P, Kobayashi H, Koch N, Königsmann K, Kolstein M, Kolster H, Korotkov V, Korsch W, Kozlov V, Kramer LH, Krivokhijine VG, Kurisuno M, Kyle G, Lachnit W, Lenisa P, Lorenzon W, Makins NCR, Martens FK, Martin JW, Masoli F, Mateos A, McAndrew M, McIlhany K, McKeown RD, Meissner F, Menden F, Metz A, Meyners N, Mikloukho O, Miller CA, Miller MA, Milner R, Most A, Muccifora V, Mussa R, Nagaitsev A, Naryshkin Y, Nathan AM, Neunreither F, Niczyporuk M, Nowak WD, Nupieri M, Oganessyan KA, O'Neill TG, Openshaw R, Ouyang J, Owen BR, Papavassiliou V, Pate SF, Pitt M, Potashov S, Potterveld DH, Rakness G, Reali A, Redwine R, Reolon AR, Ristinen R, Rith K, Rossi P, Rudnitsky S, Ruh M, Ryckbosch D, Sakemi Y, Savin I, Scarlett C, Schäfer A, Schmidt F, Schmitt H, Schnell G, Schüler KP, Schwind A, Seibert J, Shibata TA, Shibatani K, Shin T, Shutov V, Simani C, Simon A, Sinram K, Slavich P, Spengos M, Steffens E, Stenger J, Stewart J, Stoesslein U, Sutter M, Tallini H, Taroian S, Terkulov A, Teryaev O, Thomas E, Tipton B, Tytgat M, Urciuoli GM, van den Brand JFJ, van der Steenhoven G, van de Vyver R, van Hunen JJ, Vetterli MC, Vikhrov V, Vincter MG, Visser J, Volk E, Wander W, Wendland J, Williamson SE, Wise T, Woller K, Yoneyama S, Zohrabian H. Evidence for a single-spin azimuthal asymmetry in semi-inclusive pion electroproduction. Phys Rev Lett 2000; 84:4047-4051. [PMID: 10990607 DOI: 10.1103/physrevlett.84.4047] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/28/1999] [Indexed: 05/23/2023]
Abstract
Single-spin asymmetries for semi-inclusive pion production in deep-inelastic scattering have been measured for the first time. A significant target-spin asymmetry of the distribution in the azimuthal angle straight phi of the pion relative to the lepton scattering plane was formed for pi(+) electroproduction on a longitudinally polarized hydrogen target. The corresponding analyzing power in the sinstraight phi moment of the cross section is 0.022+/-0.005+/-0.003. This result can be interpreted as the effect of terms in the cross section involving chiral-odd spin distribution functions in combination with a chiral-odd fragmentation function that is sensitive to the transverse polarization of the fragmenting quark.
Collapse
|
4
|
McIlhany K, McKeown RD, Meissner F, Menden FM, Metz A, Meyners N, Mikloukho O, Miller CA, Miller MA, Milner R, Most A, Muccifora V, Naryshkin Y, Nathan AM, Neunreither F, Niczyporuk M, Nowak W, O'Neill TG, Openshaw R, Ouyang J, Owen BR, Pate SF, Potashov S, Potterveld DH, Rakness G, Redwine R. Measurement of the spin asymmetry in the photoproduction of pairs of high- p(T) hadrons at HERMES. Phys Rev Lett 2000; 84:2584-2588. [PMID: 11017275 DOI: 10.1103/physrevlett.84.2584] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/1999] [Indexed: 05/23/2023]
Abstract
We present a measurement of the longitudinal spin asymmetry A(||) in photoproduction of pairs of hadrons with high transverse momentum p(T). Data were accumulated by the HERMES experiment using a 27.5 GeV polarized positron beam and a polarized hydrogen target internal to the HERA storage ring. For h(+)h(-) pairs with p(h(1))(T)>1.5 GeV/c and p(h(2))(T)>1.0 GeV/c, the measured asymmetry is A(||) = -0. 28+/-0.12(stat)+/-0.02(syst). This negative value is in contrast to the positive asymmetries typically measured in deep inelastic scattering from protons, and is interpreted to arise from a positive gluon polarization.
Collapse
Affiliation(s)
- K McIlhany
- Yerevan Physics Institute, 375036, Yerevan, Armenia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Abstract
The purpose of this study was to determine the prevalence of perimenstrual symptoms (PMS) in a free-living population of US women and to determine if prevalence estimates varied with parity, contraceptive status, characteristics of the menstrual cycle, and selected demographic variables. We identified all households from a census listing for five southeastern city neighborhoods that offered variation in racial composition and socioeconomic status. We ascertained all households in which there was one nonpregnant woman between the ages of 18 and 35 years per household. Of the 241 eligible women, 179 (74 per cent) participated in the study. Trained interviewers administered the Moos Menstrual Distress Questionnaire (MDQ) and other demographic measures to women between March and July 1979. Symptoms with a prevalence greater than 30 per cent included weight gain, headache, skin disorders, cramps, anxiety, backache, fatigue, painful breasts, irritability, mood swings, depression, or tension. Only 2 to 8 per cent of women found most of these severe or disabling. The exceptions were severe cramps reported by 17 per cent of women and severe premenstrual and menstrual irritability by 12 per cent. Cramps, backaches, fatigue, and tension were most prevalent during the menstruum; weight gain, skin disorders, painful breasts, swelling, irritability, mood swings, and depression were more prevalent in the premenstruum. Parity, oral contraceptive use, age, employment, education, and income were negatively associated with selected PMS. Use of an IUD, having long menstrual cycles, long menstrual flow, or heavy menstrual flow, and being able to predict the next period were positively associated with selected PMS. Race had both positive and negative effects on PMS.
Collapse
|
7
|
Abstract
Recent research findings contradict the notion that premenstrual and menstrual symptoms constitute two mutually exclusive categories of perimenstrual distress. The purposes of this study were to describe the prevalence of distress associated with menstruation in a community population and to determine whether perimenstrual distress could be regarded as a single construct. Nonpregnant women (N = 193) between 18 and 35 were selected from five neighborhoods in a southeastern city in a way that allowed for variability in race and income. The women were interviewed in their homes and 179 were asked to complete the Moos Menstrual Distress Questionnaire (MDQ). At least 30% of the women reported weight gain, skin disorders, backache, painful or tender breasts, irritability, depression, headache, cramps, fatigue, swelling, mood swings or tension in the perimenstruum. Cycle phase differences were not found for 31 MDQ symptoms, but were found for: weight gain, crying, lowered school or work performance, taking naps, headache, skin disorders, cramps, anxiety, backache, fatigue, painful or tender breasts, swelling, irritability, mood swings, depression, and tension. Although there were significant differences between the premenstrual and menstrual phases for certain symptoms, the magnitudes of the mean differences were small (less than .3) except for cramps, weight gain, and fatigue. Furthermore, premenstrual and menstrual reports of the same symptoms were highly correlated. Thus, it appears reasonable to study perimenstrual distress as a single construct.
Collapse
|